KaydedilenlerDerginizi ekleyin

Dergiler / Türk Onkoloji Dergisi / 2020 / Cilt: 35 - Sayı: 3

Assessment of the Therapeutic Potential of Epigallocatechin Gallate and/or Metformin on Oral Squamous Cell Carcinoma

Nermeen ABUBAKR
Dina SABRY
Eman AHMED
Walaa IBRAHIM
Nagla ADLI
Amany NASR
Nehal Abd-El HAMEED
Sayfa
289–297
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

A combination of both showed a remarkable elevation in caspase 3 and a morepronounced decrease in all parameters.CONCLUSIONIt was concluded that EGCG exhibited a synergistic anti-proliferative, anti-angiogenic, pro-apoptoticand antioxidant activity on the Hep2 cell line when combined with metformin.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:OBJECTIVESquamous cell carcinoma is a prevalent tumor in the head and neck region.
📊
Temel Bulgular & Veri:Current treatments havelow survival rates.
💡
Sonuç & Katkı:A combination of both showed a remarkable elevation in caspase 3 and a morepronounced decrease in all parameters.CONCLUSIONIt was concluded that EGCG exhibited a synergistic anti-proliferative, anti-angiogenic, pro-apoptoticand antioxidant activity on the Hep2 cell line when combined with metformin.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

OBJECTIVESquamous cell carcinoma is a prevalent tumor in the head and neck region. Current treatments havelow survival rates. Therefore, physicians are seeking alternative therapies. This work compared the effectsof Epigallocatechin-3-gallate (EGCG), metformin and a combination of both on oral squamouscell carcinoma.METHODSThis study was performed on human epithelial type 2 (Hep2) cells. Cell viability was estimated by MTTassay. Gene expression of platelet-derived growth factor, interleukin 6, caspase 3 and survivin was evaluatedby a real-time polymerase chain reaction. Reactive oxygen species (ROS) and vascular endothelialgrowth factor were assessed by ELISA.RESULTSResults showed that cells treated with metformin showed a notable rise in caspase 3 and a significantdecrease in all parameters. EGCG had an insignificant change in all parameters tested except a significantdecrease in ROS. A combination of both showed a remarkable elevation in caspase 3 and a morepronounced decrease in all parameters.CONCLUSIONIt was concluded that EGCG exhibited a synergistic anti-proliferative, anti-angiogenic, pro-apoptoticand antioxidant activity on the Hep2 cell line when combined with metformin.

🔖

Bu Makaleye Atıf Yap

ABUBAKR, N., SABRY, D., AHMED, E., IBRAHIM, W., ADLI, N., NASR, A., HAMEED, N. A. (2022). Assessment of the Therapeutic Potential of Epigallocatechin Gallate and/or Metformin on Oral Squamous Cell Carcinoma. Türk Onkoloji Dergisi, Cilt: 35 - Sayı: 3, 289–297. https://ajindex.com/articles/639165

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Yu D, Liu Y, Yang J, Jin C, Zhao X, Cheng J, Liu X, Qi X. Clinical implications of BMI-1 in cancer stem cells of laryngeal carcinoma. Cell Biochem Biophys 2015;71(1):261–9
  2. Guzel E, Karatas OF, Ozgurses ME, Ozen M. New Insights into Laryngeal Squamous Cell Carcinoma: Cancer Stem-Like Cells. Cancer Research Frontiers 2015;1(2):138–48
  3. Wan G, Zhou L, Xie M, Chen H, Tian J. Characterization of side population cells from laryngeal cancer cell lines. Head Neck 2010;32(10):1302–9
  4. Mukhtar E, Adhami VM, Khan N, Mukhtar H. Apoptosis and autophagy induction as mechanism of cancer prevention by naturally occurring dietary agents. Curr Drug Targets 2012;13(14):1831–41
  5. Bodhade AS, Dive AM. Chemoprevention of premalignant and malignant lesions of oral cavity: Recent trends. Eur J Dent 2013;7(2):246–50
  6. Ho YC, Yang SF, Peng CY, Chou MY, Chang YC. Epigallocatechin- 3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator. J Oral Pathol Med 2007;36(10):588–93
  7. Gu Q, Hu C, Chen Q, Xia Y, Feng J, Yang H. Prevention of chinese green tea on 3,4-benzopyrene-induced lung cancer and its mechanism in animal mode. Zhongguo Fei Ai Za Zhi 2008;11(4):519–23
  8. Lee UL, Choi SW. The chemopreventive properties and therapeutic modulation of green tea polyphenols in oral squamous cell carcinoma. ISRN Oncol 2011;2011:403707
  9. Braicu C, Ladomery MR, Chedea VS, Irimie A, Berindan- Neagoe I. The relationship between the structure and biological actions of green tea catechins. Food Chem 2013;141(3):3282–9
  10. Saini N, Yang X. Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells. Acta Biochim Biophys Sin (Shanghai) 2018;50(2):133– 43
  11. Sandulache VC, Hamblin JS, Skinner HD, Kubik MW, Myers JN, Zevallos JP. Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma. Head Neck 2014;36(7):1039–43
  12. Sikka A, Kaur M, Agarwal C, Deep G, Agarwal R. Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation. Cell Cycle 2012;11(7):1374–82
  13. Yasmeen A, Beauchamp MC, Piura E, Segal E, Pollak M, Gotlieb WH. Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins. Gynecol Oncol 2011;121(3):492–8
  14. Jalving M, Gietema JA, Lefrandt JD, de Jong S, Reyners AK, Gans RO, et al. Metformin: tak